Results 61 to 70 of about 1,865 (77)

Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa‐associated lymphoid tissue (MALT lymphoma)

Ca-A Cancer Journal for Clinicians, 2016
Markus Raderer, Barbara Kiesewetter
exaly  

MALT lymphoma: from morphology to molecules

Nature Reviews Cancer, 2004
Ming-Qing Du
exaly  

CARMA1, BCL-10 and MALT1 in lymphocyte development and activation

Nature Reviews Immunology, 2004
Margot Thome
exaly  

T cell antigen receptor stimulation induces MALT1 paracaspase–mediated cleavage of the NF-κB inhibitor A20

Nature Immunology, 2008
Jens Staal, Zhijian J Chen, Rudi Beyaert
exaly  

MALT1 Small Molecule Inhibitors Specifically Suppress ABC-DLBCL In Vitro and In Vivo

Cancer Cell, 2012
Leandro Cerchietti, Rita Shaknovich, Randy D Gascoyne   +2 more
exaly  

The proteolytic activity of the paracaspase MALT1 is key in T cell activation

Nature Immunology, 2008
Daniel Rueda, Nicolas Fasel, Margot Thome   +2 more
exaly  

Pharmacologic Inhibition of MALT1 Protease by Phenothiazines as a Therapeutic Approach for the Treatment of Aggressive ABC-DLBCL

Cancer Cell, 2012
Stefani Spranger, Michael Grau, Kamyar Hadian   +2 more
exaly  

TIFA suppresses hepatocellular carcinoma progression via MALT1-dependent and -independent signaling pathways

Signal Transduction and Targeted Therapy, 2016
Wenzhi Shen, Shuangtao Zhao, Juan Wang
exaly  

The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling

Nature Communications, 2015
Theo Klein, Shan-Yu Fung, Antoine Dufour
exaly  

Constitutive NF-κB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity

Cancer Cell, 2005
Honglin Zhou, Ming-Qing Du, Vishva M Dixit   +2 more
exaly